Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -16.82 is 51% above its 5-year average of -34.30, near the high end of its 5-year range (-68.88–-16.82).
41.11% above its 12-month average of -28.56.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -4.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
EARNINGS PER SHARE (EPS)
-16.82
EARNINGS PER SHARE (EPS) AVG TTM
-28.56
EARNINGS PER SHARE (EPS) AVG 3Y
-28.65
EARNINGS PER SHARE (EPS) AVG 5Y
-34.30
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+41.11%
CURRENT VS 3Y AVG
+41.29%
CURRENT VS 5Y AVG
+50.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Lifeward Ltd.
Market Cap
$10.57M
Earnings Per Share (EPS)
-16.82
TTM Avg
-28.56
3Y Avg
-28.65
5Y Avg
-34.30
Market Cap
$10.53M
Earnings Per Share (EPS)
N/A
TTM Avg
-68.10
3Y Avg
-34.05
5Y Avg
-22.70
Market Cap
$10.52M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.21
3Y Avg
-0.25
5Y Avg
-0.25
Market Cap
$10.43M
Earnings Per Share (EPS)
-1.92
TTM Avg
-10.95
3Y Avg
-6.49
5Y Avg
-5.26
Market Cap
$10.36M
Earnings Per Share (EPS)
-0.73
TTM Avg
-0.46
3Y Avg
-0.46
5Y Avg
-0.46
Market Cap
$10.84M
Earnings Per Share (EPS)
-1.64
TTM Avg
-2.15
3Y Avg
-4.34
5Y Avg
-5.45
Market Cap
$11.08M
Earnings Per Share (EPS)
-4.43
TTM Avg
-27.97
3Y Avg
-98701.49
5Y Avg
-256134.32
Market Cap
$10.06M
Earnings Per Share (EPS)
-1.62
TTM Avg
-1.32
3Y Avg
-0.82
5Y Avg
-0.71
Market Cap
$11.12M
Earnings Per Share (EPS)
-3.20
TTM Avg
-7.58
3Y Avg
-60.73
5Y Avg
-69.78
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifeward Ltd. (LFWD) | $10.57M | -16.82 | -28.56 | -28.65 | -34.30 |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | N/A | -68.10 | -34.05 | -22.70 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.52M | N/A | -0.21 | -0.25 | -0.25 |
| Satellos Bioscience Inc. (MSLE)vs › | $10.43M | -1.92 | -10.95 | -6.49 | -5.26 |
| Caring Brands, Inc. (CABR)vs › | $10.36M | -0.73 | -0.46 | -0.46 | -0.46 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.84M | -1.64 | -2.15 | -4.34 | -5.45 |
| Cerenome, Inc. (CNSY)vs › | $11.08M | -4.43 | -27.97 | -98701.49 | -256134.32 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -1.62 | -1.32 | -0.82 | -0.71 |
| BioVie Inc. (BIVI)vs › | $11.12M | -3.20 | -7.58 | -60.73 | -69.78 |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | -0.91 | -1.65 | -2.75 | -5.28 |
Trailing EPS (TTM)
$-16.82
Forward EPS (Est.)
$-5.70
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -17.16 |
| 2024-12-31 | -39.96 |
| 2023-12-31 | -31.08 |
| 2022-12-31 | -26.40 |
| 2021-12-31 | -22.32 |
| 2020-12-31 | -68.88 |
| 2019-12-31 | -226.80 |
| 2018-12-31 | -1236.48 |
| 2017-12-31 | -2567.76 |
| 2016-12-31 | -5179.56 |
